News & Events
What treatments are approved for children and young people with MS?
We look into these in more detail to understand how the treatment decisions are made by regulators.
MS Brain Health Awards 2022 go live!
Find out more about your chance to enter the first ever MS Brain Health Awards
New MS organisations join The May 50K
Esclerosis Múltiple Argentina and the MS Society of Canada sign up to the challenge
Researchers strengthen the link between Epstein-Barr Virus (EBV) and the risk of developing MS
Does EBV cause MS?
Uruguay’s MS Compass
Esclerosis Múltiple Uruguay creates a digital tool to help people understand and live better with MS.
Fixing an imperfect system through the voices of those with lived experience
Find out more about the Global PROMS Initiative - Patient Reported Outcomes for MS
Mesenchymal stem cell therapy for MS – results of international trial
Global trial of mesenchymal stem cell therapy showed no reduction in inflammation for people with active MS
Let’s talk about myelin
To stop MS, we need treatments that repair damage to the protective myelin coating around nerves.
Mapping out the global research agenda to end progressive MS
Leaders of the International Progressive MS Alliance have published a paper proposing a global research strategy to…
2021 McDonald Fellowships and Du Pré Grant recipients announced
MSIF is proud to announce the recipients of the 2021 McDonald Fellowships and Du Pré Grants, from…
Answering questions on fatigue in progressive MS
Catch up on the latest webcast on fatigue treatment and research from the International Progressive MS Alliance
Progressive MS Alliance – MS stories from across the world
Find out about the lives of seven people affected by progressive MS.